@csl.com
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Logo
SVG
Icon
JPEG
About
Description
CSL Limited (CSL) is a global biotechnology company based in Australia. It was founded in 1916 and has its headquarters in Parkville, a suburb of Melbourne, Victoria. CSL started as the Commonwealth Serum Laboratories, which was established to produce antitoxins and vaccines.
Over the years, it expanded its operations and diversified its product offerings. Today, CSL is a leading provider of innovative biotherapies and influenza vaccines. The company's main product lines include plasma-derived therapies such as immunoglobulins, clotting factors, and albumin.
These products are used to treat a range of medical conditions including immune deficiencies, hemophilia, and burns. CSL operates on a global scale with operations in more than 30 countries. The company has a number of noteworthy subsidiaries, joint ventures, and partnerships.
One of its subsidiaries, CSL Behring, focuses on developing and manufacturing plasma-derived and recombinant protein-based therapies. CSL Behring has a strong presence in the global market and is known for its high-quality products. In terms of market position, CSL is considered one of the top players in the biotechnology industry.
The company has achieved significant success in recent years, with strong global sales and a solid reputation among its competitors. CSL's commitment to research and development has allowed it to introduce new and innovative products, helping to strengthen its market position further. In terms of major events and achievements, CSL has made significant advancements in the development of vaccines and therapies.
In 2020, the company played a critical role in the development and production of a plasma-derived therapy to treat COVID-19. CSL's contribution to fighting the pandemic was widely recognized and highlighted its dedication to public health. As of the latest update, CSL continues to grow and expand its presence in the global biotechnology market.
The company remains committed to driving innovation and providing life-saving therapies to patients worldwide. CSL's strong financial performance and ongoing research efforts position it as a major player in the industry
Company Type
Public Company
Company Size
10,001+
Year Founded
1916
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online